Celcuity Inc. Company Profile
NASDAQ: CELCHealth CareMedical SpecialitiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Celcuity at a glance
Celcuity Inc. (NASDAQ: CELC) is a Medical Specialities company in the Health Care sector headquartered in Minneapolis, MN. Celcuity is led by Mr. Brian F. Sullivan and employs about 155 people. The company's shares have traded publicly since 2017.
At a market capitalization of $3.22 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001603454, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Celcuity do?
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.
Business description based on the company's public filings.
Company information
- Legal name
- Celcuity Inc.
- Ticker
- NASDAQ: CELC
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. Brian F. Sullivan
- Employees
- 155
- Headquarters
- 2800 Campus Drive, Minneapolis, MN, United States
- Phone
- (763) 392-0123
- Website
- celcuity.com
- IPO year
- 2017
- Market cap
- $3.22B
- SEC CIK
- 0001603454
- Latest annual report
- 10-K · Mar 26, 2026
Companies similar to Celcuity
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CDNACareDx Inc. | 63.04 | -1.18% | $3.26B | vs CELC |
| VCYTVeracyte Inc. | 43.16 | -3.34% | $3.47B | vs CELC |
| ACHCAcadia Healthcare Company Inc. | 29.23 | +0.65% | $2.72B | vs CELC |
| FTREFortrea Holdings Inc. | 20.56 | -1.06% | $1.96B | vs CELC |
| BLLNBillionToOne Inc. Class A | 95.75 | -4.19% | $4.52B | vs CELC |
| CONConcentra Group Holdings Parent Inc. | 36.40 | 0.00% | $4.64B | vs CELC |
| PSNLPersonalis Inc. | 16.00 | -0.19% | $1.71B | vs CELC |
| RDNTRadNet Inc. | 68.61 | -2.38% | $5.40B | vs CELC |